Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00296764 · ClinicalTrials.gov registry record
Characterization of Angelman Syndrome
A clinical trial of Angelman Syndrome, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 302
- Enrollment target
- 6
- Study locations
NCT00296764: Completed study of Angelman Syndrome, sponsored by Boston Children's Hospital.
NCT00296764 is a study of Angelman Syndrome that has completed, run by Boston Children's Hospital. The registered enrollment target is 302 participants, above the 99-participant average among 11 other Angelman Syndrome trials with a reported enrollment target (205% higher). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00296764, a study of Angelman Syndrome, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 302 participants
- Enrollment target
- 6
- Study locations
Study Summary
Angelman Syndrome (AS) is a developmental disorder that is caused by a deficiency of a maternally transmitted gene. It is inherited at birth, and affects movement, speech, and social demeanor. This study will gain a better understanding of the disease progression and clinical features of AS by observing children with AS over an extended period of time.
Primary Outcome
to characterize the medical problems associated with Angelman syndrome, and to determine the relative prevalence of those problems in the different molecular subclasses of Angelman syndrome
Conditions Studied
Study Locations (6)
California
- Rady Children's Hospital San Diego - San Diego
Massachusetts
- Boston Children's Hospital - Boston
Ohio
- Cincinnati Children's Hospital and Medical Center - Cincinnati
South Carolina
- Greenwood Genetic Center - Greenwood
Tennessee
- Vanderbilt University Medical Center - Nashville
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 302 participants |
| Start Date | 2006-02 |
| Est. Completion | 2014-08 |
What the finished NCT00296764 record still lists
NCT00296764 is an observational study that tracks outcomes without assigning an intervention. The registered 302 participants enrollment target is mid-sized for trials with a published cap, above the 99-participant average among 11 other Angelman Syndrome trials with a reported enrollment target (205% higher).
The record links to 1 condition, with Angelman Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT00296764 lists 6 locations in 6 states (California, Massachusetts, Ohio).
Frequently Asked Questions
What is clinical trial NCT00296764 about?
NCT00296764 is a clinical study titled "Characterization of Angelman Syndrome". Angelman Syndrome (AS) is a developmental disorder that is caused by a deficiency of a maternally transmitted gene. It is inherited at birth, and affects movement, speech, and social demeanor. This study will gain a better understanding of the disease progression and clinical features of AS by obser...
What is the current status of trial NCT00296764?
This trial is currently completed. The enrollment target is 302 participants. The study started on 2006-02. Estimated completion is 2014-08.
What conditions does trial NCT00296764 study?
This clinical trial studies the following conditions: Angelman Syndrome.
Who is sponsoring clinical trial NCT00296764?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00296764 being conducted?
This trial has 6 study locations across California, Massachusetts, Ohio, South Carolina, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Angelman Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00296764's enrollment target sits among peer trials
302 1st of 11 higher than 11 of 11 other Angelman Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Angelman Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Angelman Syndrome Natural History Study
RECRUITING
-
REVEAL: A Phase 3 Study of ION582 in Angelman Syndrome
RECRUITING · Phase 3
-
A Phase 1/2 Study of the Safety and Efficacy of MVX-220 in Angelman Syndrome
RECRUITING · Phase 1
-
Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)
RECRUITING · NA
-
A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS)
RECRUITING · Phase 2
-
HALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Ascending Doses of ION582 in Participants With Angelman Syndrome
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05722561 · 302 participants · Phase 2
E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
- NCT06015737 · 302 participants · Phase 3
A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
- NCT07176273 · 302 participants · NA
Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)
- NCT05508971 · 303 participants · NA
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia